Omega Healthcare Investors, Inc. (NYSE:OHI – Get Free Report) CIO Vikas Gupta purchased 11,500 shares of the stock in a transaction on Thursday, November 6th. The stock was acquired at an average cost of $42.97 per share, for a total transaction of $494,155.00. Following the completion of the acquisition, the executive owned 13,773 shares of the company’s stock, valued at $591,825.81. The trade was a 505.94% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Omega Healthcare Investors Stock Performance
Shares of NYSE OHI traded down $0.43 during trading on Thursday, reaching $42.59. 1,679,660 shares of the company traded hands, compared to its average volume of 2,245,300. The stock has a market cap of $12.56 billion, a P/E ratio of 26.29, a PEG ratio of 1.85 and a beta of 0.69. The firm’s fifty day simple moving average is $41.50 and its 200 day simple moving average is $39.23. The company has a current ratio of 7.10, a quick ratio of 7.10 and a debt-to-equity ratio of 0.96. Omega Healthcare Investors, Inc. has a 12-month low of $35.04 and a 12-month high of $43.54.
Omega Healthcare Investors (NYSE:OHI – Get Free Report) last posted its earnings results on Thursday, October 30th. The real estate investment trust reported $0.79 EPS for the quarter, topping the consensus estimate of $0.77 by $0.02. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The firm had revenue of $260.74 million for the quarter, compared to analyst estimates of $262.48 million. During the same period last year, the company earned $0.71 earnings per share. Omega Healthcare Investors’s revenue for the quarter was up 14.4% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.080-3.100 EPS. As a group, research analysts anticipate that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.
Omega Healthcare Investors Announces Dividend
Analysts Set New Price Targets
A number of research analysts have weighed in on the stock. Scotiabank upped their price objective on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the stock a “sector perform” rating in a research report on Thursday, August 28th. Wells Fargo & Company boosted their price objective on Omega Healthcare Investors from $44.00 to $45.00 and gave the company an “overweight” rating in a research report on Tuesday, October 21st. Truist Financial increased their target price on Omega Healthcare Investors from $39.00 to $44.00 and gave the company a “hold” rating in a research report on Wednesday, September 3rd. Mizuho boosted their price target on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the stock a “neutral” rating in a report on Thursday, September 11th. Finally, Royal Bank Of Canada increased their price objective on shares of Omega Healthcare Investors from $41.00 to $44.00 and gave the company a “sector perform” rating in a report on Thursday. Five research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $44.29.
View Our Latest Report on Omega Healthcare Investors
Institutional Investors Weigh In On Omega Healthcare Investors
A number of large investors have recently modified their holdings of OHI. Vanguard Group Inc. lifted its stake in shares of Omega Healthcare Investors by 3.1% in the second quarter. Vanguard Group Inc. now owns 40,765,481 shares of the real estate investment trust’s stock worth $1,494,055,000 after buying an additional 1,210,595 shares in the last quarter. State Street Corp raised its holdings in Omega Healthcare Investors by 4.8% in the 2nd quarter. State Street Corp now owns 14,591,873 shares of the real estate investment trust’s stock valued at $534,792,000 after acquiring an additional 671,473 shares during the last quarter. Geode Capital Management LLC raised its holdings in Omega Healthcare Investors by 4.6% in the 2nd quarter. Geode Capital Management LLC now owns 7,377,761 shares of the real estate investment trust’s stock valued at $270,426,000 after acquiring an additional 326,595 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in Omega Healthcare Investors by 2.4% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 4,201,353 shares of the real estate investment trust’s stock worth $153,980,000 after purchasing an additional 100,462 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of Omega Healthcare Investors by 4.3% during the 1st quarter. Dimensional Fund Advisors LP now owns 4,058,107 shares of the real estate investment trust’s stock worth $154,533,000 after purchasing an additional 165,554 shares during the last quarter. Hedge funds and other institutional investors own 65.25% of the company’s stock.
About Omega Healthcare Investors
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.
Featured Articles
- Five stocks we like better than Omega Healthcare Investors
- Using the MarketBeat Stock Split Calculator
- CAVA Stock Looking for Direction After Earnings Miss
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- 3 Small AI Stocks Ready to Explode (All Under $20)
- How to Calculate Inflation Rate
- After 16% Fall, Analysts Eye a Big Recovery in Meta Platforms
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
